Herpes simplex virus (HSV) infections in humans result in sporadic but recurrent lesions that appear at the site of the initial infection, and are now known to be the result of the reactivation of latent virus that resides within sensory neurons. As a large percentage of the human population experience some form of HSV infection, this virus represents a significant health issue. In this application, we propose a series of experiments that will investigate the cellular mechanisms that control the reactivation of latent HSV in sensory neurons. Based on prior studies of the response of peripheral neurons to axotomy, and the finding that the axotomy of sensory neurons triggers HSV reactivation, we hypothesize that a combination of neurotrophin withdrawal and cytokine secretion triggers HSV reactivation. To test this hypothesis and to identify intracellular signaling mechanisms that control HSV reactivation, we propose the following aims: 1. To characterize the sensory neurons that support ESV reactivation from latency by examining the expression of neurotrophin and cytokine receptors in latently infected neurons that are induced to support HSV reactivation. 2. To use neurotrophins, cytokines, and specific blockers of these factors to examine whether neurotrophins and cytokines regulate HSV latency and reactivation. 3. To identify the intracellular signaling pathways that are activated by extracellular stimuli that induce HSV reactivation in latently infected neurons, and to determine if these specific pathways play a critical role in regulating HSV latency and reactivation. Taken together, these aims will provide new insight into the cellular mechanisms that control the reactivation of latent HSV and may allow the generation of new therapeutics that could help to inhibit the reactivation process.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Program Projects (P01)
Project #
2P01NS035138-15
Application #
6546151
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Project Start
1996-05-01
Project End
2006-07-31
Budget Start
Budget End
Support Year
15
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02215
Lutz, Gabriel; Jurak, Igor; Kim, Eui Tae et al. (2017) Viral Ubiquitin Ligase Stimulates Selective Host MicroRNA Expression by Targeting ZEB Transcriptional Repressors. Viruses 9:
Pan, Dongli; Kaye, Stephen B; Hopkins, Mark et al. (2014) Common and new acyclovir resistant herpes simplex virus-1 mutants causing bilateral recurrent herpetic keratitis in an immunocompetent patient. J Infect Dis 209:345-9
Pan, Dongli; Flores, Omar; Umbach, Jennifer L et al. (2014) A neuron-specific host microRNA targets herpes simplex virus-1 ICP0 expression and promotes latency. Cell Host Microbe 15:446-56
Jurak, Igor; Hackenberg, Michael; Kim, Ju Youn et al. (2014) Expression of herpes simplex virus 1 microRNAs in cell culture models of quiescent and latent infection. J Virol 88:2337-9
Wang, Jennifer P; Bowen, Glennice N; Zhou, Shenghua et al. (2012) Role of specific innate immune responses in herpes simplex virus infection of the central nervous system. J Virol 86:2273-81
Jurak, Igor; Griffiths, Anthony; Coen, Donald M (2011) Mammalian alphaherpesvirus miRNAs. Biochim Biophys Acta 1809:641-53
Kramer, Martha F; Jurak, Igor; Pesola, Jean M et al. (2011) Herpes simplex virus 1 microRNAs expressed abundantly during latent infection are not essential for latency in mouse trigeminal ganglia. Virology 417:239-47
Kramer, Martha F (2011) Stem-loop RT-qPCR for miRNAs. Curr Protoc Mol Biol Chapter 15:Unit 15.10
Jurak, Igor; Kramer, Martha F; Mellor, Joseph C et al. (2010) Numerous conserved and divergent microRNAs expressed by herpes simplex viruses 1 and 2. J Virol 84:4659-72
Kushnir, Anna S; Davido, David J; Schaffer, Priscilla A (2010) Role of nuclear factor Y in stress-induced activation of the herpes simplex virus type 1 ICP0 promoter. J Virol 84:188-200

Showing the most recent 10 out of 57 publications